TENX - Bathi operasional EBITDA Tenax Therapeutics Inc.

The development of the pulmonary hypertension product line is driving growth for Tenax Therapeutics (TENX), as evidenced by the EBITDA cash flow dynamics. 0.00 indicates the current level of this performance metric. Growth is supported by patents for the unique Levosimendan molecule and the implementation of robotic systems in clinical trials, which minimize data collection errors.

Tenax Therapeutics Inc (TENX) - Bathi operasional sadurunge ngurangi amortisasi saka 23.11.2025 nganti 12.11.2026

Tenax Therapeutics, Inc. (TENX) - rincian metrik lan laporan keuangan

- rega saham lan prakiraan rega para ahli:

Kurs saham Tenax Therapeutics Inc|TENX - Prakiraan konsensus analis

- statistik kapitalisasi pasar:

Kapitalisasi pasar Tenax Therapeutics|TENX - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- indikator nilai buku ekuitas:

Ekuitas saben Saham Tenax Therapeutics|TENX - Aset Bersih Perusahaan|Nilai Pasar marang Nilai Buku tenaxthera.com|TENX - Gunggung Aset Perusahaan

- indikator total utang lan likuiditas perusahaan:

Utang Agregat marang Modal Tenax Therapeutics|TENX - Utang jangka dawa marang modal|Rasio tanggungan utang jangka cendhak marang modal Tenax Therapeutics Inc.|TENX - Gunggung utang perusahaan|Utang-utang marang nilai buku Tenax Therapeutics|TENX - Utang jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Tenax Therapeutics|Rasio cepet tenaxthera.com

- indikator bathi lan kelipatan valuasi:

TENX - Bathi resik perusahaan|Bathi forward Tenax Therapeutics|TENX - Pangali P/E|Rasio prakiraan rega marang bathi tenaxthera.com|TENX - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA Tenax Therapeutics|TENX - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone patang kuartal pungkasan Tenax Therapeutics|TENX - Bathi resik saben saham (EPS TTM)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan tenaxthera.com|TENX - Wutah bathi ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Tenax Therapeutics

Ringkesan analitik perusahaan:Tenax Therapeutics

The selection of high-quality issuers is based on an analysis of the business's ability to generate cash flow free from the impact of tax burdens, debt obligations, and asset depreciation. This EBITDA trend reflects the real operational efficiency of Tenax Therapeutics (TENX), which, amid geopolitical risks and supply chain disruptions for cardiovascular drug raw materials, allows for an assessment of the company's resilience to external shocks.

Pesaing Tenax Therapeutics (TENX)

REGN: Bathi operasional sadurunge amortisasi|iRhythm Technologies - Bathi operasional EBITDA|LNTH - Bathi operasional EBITDA|MLYS (Mineralys Therapeutics, Inc.) - Bathi operasional sadurunge ngurangi amortisasi|Bathi operasional sadurunge amortisasi HTFL|Bathi operasional sadurunge ngurangi amortisasi KMTS|ESPR: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional sadurunge ngurangi amortisasi AMRN (Amarin Corporation plc)|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi AVR|Bathi operasional EBITDA TNYA (Tenaya Therapeutics, Inc.)|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi CVRX|Milestone Pharma - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Cardiol Therapeutics|HeartBeam, Inc. (BEAT) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|adagiomedical.com - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|BCDA (BioCardia) - Bathi operasional EBITDA|Bathi operasional EBITDA Catheter Precision Inc|Bathi sadurunge mbayar bunga, pajak, lan amortisasi ARCA Biopharma (ABIO)|ACST: Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi operasional EBITDA AVTE (Aerovate Therapeutics)|Verve Therapeutics Inc. (VERV) - Bathi sadurunge bunga, pajak, lan amortisasi|WINT: Bathi operasional sadurunge ngurangi amortisasi